Literature DB >> 20394097

Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase.

Duangnapa Kovanich1, Marcel A G van der Heyden, Thin Thin Aye, Toon A B van Veen, Albert J R Heck, Arjen Scholten.   

Abstract

The compartmentalization of kinases and phosphatases plays an important role in the specificity of second-messenger-mediated signaling events. Localization of the cAMP-dependent protein kinase is mediated by interaction of its regulatory subunit (PKA-R) with the versatile family of A-kinase-anchoring proteins (AKAPs). Most AKAPs bind avidly to PKA-RII, while some have dual specificity for both PKA-RI and PKA-RII; however, no mammalian PKA-RI-specific AKAPs have thus far been assigned. This has mainly been attributed to the observation that PKA-RI is more cytosolic than the more heavily compartmentalized PKA-RII. Chemical proteomics screens of the cAMP interactome in mammalian heart tissue recently identified sphingosine kinase type 1-interacting protein (SKIP, SPHKAP) as a putative novel AKAP. Biochemical characterization now shows that SPHKAP can be considered as the first mammalian AKAP that preferentially binds to PKA-RIalpha. Recombinant human SPHKAP functions as an RI-specific AKAP that utilizes the characteristic AKAP amphipathic helix for interaction. Further chemical proteomic screening utilizing differential binding characteristics of specific cAMP resins confirms SPHKAPs endogenous specificity for PKA-RI directly in mammalian heart and spleen tissue. Immunolocalization studies revealed that recombinant SPHKAP is expressed in the cytoplasm, where PKA-RIalpha also mainly resides. Alignment of SPHKAPs' amphipathic helix with peptide models of PKA-RI- or PKA-RII-specific anchoring domains shows that it has largely only PKA-RIalpha characteristics. Being the first mammalian PKA-RI-specific AKAP with cytosolic localization, SPHKAP is a very promising model for studying the function of the less explored cytosolic PKA-RI signaling nodes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394097     DOI: 10.1002/cbic.201000058

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  39 in total

1.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 2.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  The identification of novel cyclic AMP-dependent protein kinase anchoring proteins using bioinformatic filters and peptide arrays.

Authors:  William A McLaughlin; Tingjun Hou; Susan S Taylor; Wei Wang
Journal:  Protein Eng Des Sel       Date:  2010-11-29       Impact factor: 1.650

Review 4.  Pseudoscaffolds and anchoring proteins: the difference is in the details.

Authors:  Stacey Aggarwal-Howarth; John D Scott
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

Review 5.  AKAP phosphatase complexes in the heart.

Authors:  John M Redden; Kimberly L Dodge-Kafka
Journal:  J Cardiovasc Pharmacol       Date:  2011-10       Impact factor: 3.105

Review 6.  Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

Authors:  Joel S Karliner
Journal:  Biochim Biophys Acta       Date:  2012-06-23

7.  AKAP18:PKA-RIIα structure reveals crucial anchor points for recognition of regulatory subunits of PKA.

Authors:  Frank Götz; Yvette Roske; Maike Svenja Schulz; Karolin Autenrieth; Daniela Bertinetti; Katja Faelber; Kerstin Zühlke; Annika Kreuchwig; Eileen J Kennedy; Gerd Krause; Oliver Daumke; Friedrich W Herberg; Udo Heinemann; Enno Klussmann
Journal:  Biochem J       Date:  2016-04-21       Impact factor: 3.857

8.  PKA-type I selective constrained peptide disruptors of AKAP complexes.

Authors:  Yuxiao Wang; Tienhuei G Ho; Eugen Franz; Jennifer S Hermann; F Donelson Smith; Heidi Hehnly; Jessica L Esseltine; Laura E Hanold; Mandi M Murph; Daniela Bertinetti; John D Scott; Friedrich W Herberg; Eileen J Kennedy
Journal:  ACS Chem Biol       Date:  2015-03-25       Impact factor: 5.100

9.  Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.

Authors:  Masashi Ikeda; Atsushi Takahashi; Yoichiro Kamatani; Yukihide Momozawa; Takeo Saito; Kenji Kondo; Ayu Shimasaki; Kohei Kawase; Takaya Sakusabe; Yoshimi Iwayama; Tomoko Toyota; Tomoyasu Wakuda; Mitsuru Kikuchi; Nobuhisa Kanahara; Hidenaga Yamamori; Yuka Yasuda; Yuichiro Watanabe; Satoshi Hoya; Branko Aleksic; Itaru Kushima; Heii Arai; Manabu Takaki; Kotaro Hattori; Hiroshi Kunugi; Yuko Okahisa; Tohru Ohnuma; Norio Ozaki; Toshiyuki Someya; Ryota Hashimoto; Takeo Yoshikawa; Michiaki Kubo; Nakao Iwata
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

10.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.